Robert G Uzzo
Biographic Data
| ID | 5537577 |
|---|---|
| NAME | Robert G Uzzo |
| GIVEN NAMES | Robert G |
| FAMILY NAME | Uzzo |
| SIGNATURE | UZZO R G |
| AFFILIATIONS | Fox Chase Cancer Center |
| ORCID | 0000-0003-2398-6530 |
| VERIFIED | Yes |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 18 |
| AUTHOR COUNT | 5 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 1988 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 1 |
Investigating the Usage of Abiraterone in African American Men with Metastatic Prostate Cancer
Trends in Regionalization of Care and Mortality For Patients Treated With Radical Cystectomy
BACKGROUND: Regionalization to higher volume centers has been proposed as a mechanism to improve short-term outcomes following complex surgery. OBJECTIVE: The objective of this study was to assess trends in regionalization and mortality for patients undergoing radical cystectomy (RC). RESEARCH DESIGN: An observational study of patients receiving RC in the United States from 2004 to 2013. SUBJECTS: Data for patients receiving RC were extracted fro…
Understanding Treatment Disconnect and Mortality Trends in Renal Cell Carcinoma Using Tumor Registry Data
BACKGROUND AND OBJECTIVES: The paradoxical rise in overall and cancer-specific mortality despite increased detection and treatment of renal cell carcinoma (RCC) is termed "treatment disconnect." We reassess this phenomenon by evaluating impact of missing data and rising incidence on mortality trends. RESEARCH DESIGN, SUBJECTS, AND MEASURES: Using Surveillance, Epidemiology, and End Results data, we identified patients with RCC diagnosis from 1973…
Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score Work
BACKGROUND: Comorbidity adjustment is an important component of health services research and clinical prognosis. When adjusting for comorbidities in statistical models, researchers can include comorbidities individually or through the use of summary measures such as the Charlson Comorbidity Index or Elixhauser score. We examined the conditions under which individual versus summary measures are most appropriate. METHODS: We provide an analytic pro…
Food preferences in families
Food preferences in families
Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score Work
BACKGROUND: Comorbidity adjustment is an important component of health services research and clinical prognosis. When adjusting for comorbidities in statistical models, researchers can include comorbidities individually or through the use of summary measures such as the Charlson Comorbidity Index or Elixhauser score. We examined the conditions under which individual versus summary measures are most appropriate. METHODS: We provide an analytic pro…
Understanding Treatment Disconnect and Mortality Trends in Renal Cell Carcinoma Using Tumor Registry Data
BACKGROUND AND OBJECTIVES: The paradoxical rise in overall and cancer-specific mortality despite increased detection and treatment of renal cell carcinoma (RCC) is termed "treatment disconnect." We reassess this phenomenon by evaluating impact of missing data and rising incidence on mortality trends. RESEARCH DESIGN, SUBJECTS, AND MEASURES: Using Surveillance, Epidemiology, and End Results data, we identified patients with RCC diagnosis from 1973…
Trends in Regionalization of Care and Mortality For Patients Treated With Radical Cystectomy
BACKGROUND: Regionalization to higher volume centers has been proposed as a mechanism to improve short-term outcomes following complex surgery. OBJECTIVE: The objective of this study was to assess trends in regionalization and mortality for patients undergoing radical cystectomy (RC). RESEARCH DESIGN: An observational study of patients receiving RC in the United States from 2004 to 2013. SUBJECTS: Data for patients receiving RC were extracted fro…
Investigating the Usage of Abiraterone in African American Men with Metastatic Prostate Cancer
Medicine (5 works) · Demography (4 works) · Internal Medicine (4 works) · Cancer (3 works) · Internal Medicine (3 works) · Epidemiology (2 works) · Mortality rate (2 works) · Oncology (2 works) · Abiraterone (1 works) · Androgen deprivation therapy (1 works)